Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (6 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
2 selected
)
Type
Guidance (6)
NICE advice (0)
Guidance programme
(
3 selected
)
Guidance programme
Antimicrobial prescribing guidelines (1)
Clinical guidelines (2)
Diagnostics guidance (0)
Highly specialised technologies guidance (0)
Interventional procedures guidance (7)
Medical technologies guidance (3)
NICE guidelines (3)
Social care guidelines (1)
Technology appraisal guidance (6)
Apply filters
Showing 1 to 6 of 6
Sort by
Date
Title
Apply sorting
Last updated date between 1/1/2019 and 28/2/2019
Remove Last updated date between 1/1/2019 and 28/2/2019 filter
Type: Guidance
Remove Type: Guidance filter
Type: NICE advice
Remove Type: NICE advice filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia
TA561
27 February 2019
27 February 2019
Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanoma
TA562
27 February 2019
27 February 2019
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
TA563
27 February 2019
27 February 2019
Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal)
TA560
20 February 2019
20 February 2019
Regorafenib for previously treated advanced hepatocellular carcinoma
TA555
9 January 2019
9 January 2019
Darvadstrocel for treating complex perianal fistulas in Crohn's disease
TA556
9 January 2019
9 January 2019
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top